Inify Laboratories AB
AI-powered digital pathology lab providing fast cancer diagnostics for healthcare providers.
INIFY | ST
Overview
Corporate Details
- ISIN(s):
- SE0017486103
- LEI:
- 549300306YYJ3BX3VB98
- Country:
- Sweden
- Address:
- Scheeles väg 3, 171 65 Solna
- Website:
- https://www.inify.com/
- Sector:
- Human health and social work activities
- Industry:
- Other human health activities
Description
Inify Laboratories AB provides cancer diagnostics through ultramodern laboratory services within pathology. The company operates a fully digital, standardized, and AI-supported workflow designed to optimize diagnostic quality and significantly reduce turnaround times for biopsy results. Initially specializing in prostate cancer diagnostics with its "Inify Prostate" decision support tool, the company has achieved a significant market share in Stockholm and is expanding into other areas, such as gastrointestinal diagnostics. Inify Laboratories serves healthcare providers and is undergoing international expansion, including into the UK market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-29 11:16 |
Quarterly Report
|
Swedish | 1.7 MB | ||
| 2025-10-29 11:16 |
Quarterly Report
|
English | 1.7 MB | ||
| 2025-10-29 11:15 |
Quarterly Report
Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet ha…
|
Swedish | 1.7 MB | ||
| 2025-10-29 11:15 |
Quarterly Report
Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and…
|
English | 1.7 MB | ||
| 2025-10-29 11:15 |
Quarterly Report
Correction - Inify Laboratories: Første gastrointestinale diagnoser levert og k…
|
English | 1.7 MB | ||
| 2025-10-29 11:15 |
Earnings Release
Korrigering - Inify Laboratories: De första diagnoserna inom mag-tarmområdet ha…
|
Swedish | 4.8 KB | ||
| 2025-10-29 11:15 |
Earnings Release
Correction - Inify Laboratories: First gastrointestinal diagnoses delivered and…
|
English | 4.5 KB | ||
| 2025-10-29 11:15 |
Earnings Release
Correction - Inify Laboratories: Første gastrointestinale diagnoser levert og k…
|
Norwegian | 4.5 KB | ||
| 2025-10-29 08:00 |
Quarterly Report
Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virkso…
|
English | 1.7 MB | ||
| 2025-10-29 08:00 |
Quarterly Report
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical …
|
English | 1.7 MB | ||
| 2025-10-29 08:00 |
Quarterly Report
Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats o…
|
Swedish | 1.7 MB | ||
| 2025-10-29 08:00 |
Earnings Release
Inify Laboratories: Første gastrointestinale diagnoser levert og klinisk virkso…
|
Norwegian | 4.1 KB | ||
| 2025-10-29 08:00 |
Earnings Release
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical …
|
English | 4.2 KB | ||
| 2025-10-29 08:00 |
Earnings Release
Inify Laboratories: De första diagnoserna inom mag-tarmområdet har levererats o…
|
Swedish | 4.5 KB | ||
| 2025-10-29 08:00 |
Quarterly Report
Inify Laboratories: First gastrointestinal diagnoses delivered and UK clinical …
|
English | 1.7 MB |
Automate Your Workflow. Get a real-time feed of all Inify Laboratories AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Inify Laboratories AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Inify Laboratories AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-29 | Olof Sandén | Other | Buy | 10,000 | 44,800.00 SEK |
| 2025-01-27 | Olof Sandén | Other | Buy | 6,840 | 28,659.60 SEK |
| 2023-07-05 | Magne Jordanger | Other | Buy | 650,000 | 6,500,000.00 EUR |
| 2022-08-19 | Magne Jordanger | Other | Buy | 336,950 | 2,560,820.00 EUR |
